SCHEMBL20312468

SCHEMBL20312468

CC1(C)COB(c2ccccn2)OC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ CCR1 P32246 1/20 0.31
▸ CCR5 P51681 1/20 0.31
▸ CCR8 P51685 1/20 0.31
▸ METAP1 P53582 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ HIF1A Q16665 1/20 0.31
▸ DOHH Q9BU89 1/20 0.31
▸ P4HTM Q9NXG6 1/20 0.31
▸ SOAT1 P35610 1/20 0.31
▸ CA1 P00915 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29749739 1.00 SLC6A2 (0.33) SLC6A2HTTKMT2ASMN1; SMN2ALDH1A1
SCHEMBL18362682 0.83 SLC6A2 (0.31) SLC6A2
SCHEMBL1441345 0.81 KDM4E (0.39) HTTKMT2ASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL20312465 0.77 — —
SCHEMBL20312464 0.77 HSP90AA1 (0.31) —
SCHEMBL20312455 0.77 SNCA (0.33) SNCA
SCHEMBL29498702 0.76 LPL (0.44) KMT2AALDH1A1KDM4ELMNACYP1A2
SCHEMBL5065663 0.76 KDM4E (0.34) HTTKMT2ASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL708737 0.76 LPL (0.44) KMT2AALDH1A1KDM4ELMNACYP1A2
SCHEMBL20312457 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10504732-B2 Impurity diffusion agent composition and method for manufacturing semiconductor substrate TOKYO OHKA KOGYO CO, LTD. (JP) 2019-12-10 — — US disclosed
US-20180182624-A1 IMPURITY DIFFUSION AGENT COMPOSITION AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE TOKYO OHKA KOGYO CO., LTD. (JP) 2018-06-28 — — US disclosed
US-20180182624-A1 IMPURITY DIFFUSION AGENT COMPOSITION AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE TOKYO OHKA KOGYO CO., LTD. (JP) 2018-06-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180182624-A1 IMPURITY DIFFUSION AGENT COMPOSITION AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE SLC43A1, SAMHD1, SNRPD2 SLC6A2 52/4885HTT 2250/4885KMT2A 2756/4885
US-10504732-B2 Impurity diffusion agent composition and method for manufacturing semiconductor substrate SLC43A1, SAMHD1, SNRPD2 SLC6A2 52/4885HTT 2250/4885KMT2A 2756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback